Evidence map›Paper›PMID 42378105›Full record

ArticleACS applied bio materials2026

Heparinized Elastomeric Nanofibrillar Grafts: Mechanically Tunable, Cell-Supportive, and Thromboresistant Vascular Substitutes.

Elizabeth C Zermeno, John M Kapitan, Alexander D Sandquist, Amanda Reke, Apurbo Kumar Paul, Jason N MacTaggart, Stephen A Morin, Kaspars Maleckis

Abstract read
In one paragraph

Article in ACS applied bio materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Elizabeth C ZermenoDepartment of Biomechanics, University of Nebraska at Omaha, Omaha, Nebraska 68182, United States.ORCID 0009-0006-3433-3382
John M KapitanDepartment of Chemistry, University of Nebraska-Lincoln, Lincoln, Nebraska 68588, United States.
Alexander D SandquistDepartment of Chemistry, University of Nebraska-Lincoln, Lincoln, Nebraska 68588, United States.
Amanda RekeDepartment of Biomechanics, University of Nebraska at Omaha, Omaha, Nebraska 68182, United States.
Apurbo Kumar PaulDepartment of Biomechanics, University of Nebraska at Omaha, Omaha, Nebraska 68182, United States.
Jason N MacTaggartDepartment of Surgery, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States.
Stephen A MorinDepartment of Chemistry, University of Nebraska-Lincoln, Lincoln, Nebraska 68588, United States.
Kaspars MaleckisDepartment of Biomechanics, University of Nebraska at Omaha, Omaha, Nebraska 68182, United States.ORCID 0000-0003-4477-2435

Funding

Using Patient-Reported Outcomes, Inflammatory Profiles, and Cardiovascular Phenogroups to Expand the Definition of Heart Failure with Preserved Ejection FractionP20GM152326 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Rebekah L. Gundry · 2024 to 2026
$10.3M
Tissue Analysis Core (TAC)P20GM152301 · NIGMS · UNIVERSITY OF NEBRASKA OMAHA · PI Yury Salkovskiy · 2024 to 2026
$8.8M
Axially Prestretched Elastomeric Graft (APENG) for Lower Extremity Arterial ReconstructionsR61HL173890 · NHLBI · UNIVERSITY OF NEBRASKA OMAHA · PI MALECKIS, KASPARS · 2024 to 2025
$744k
NHLBI NIH HHS R61 HL173890NIGMS NIH HHS P20 GM152301NIGMS NIH HHS P20 GM152326
6 · The paper itself

Abstract

The clinical success of vascular grafts relies on three main prerequisites: artery-tuned mechanics, a cell-supportive microstructure, and a thromboresistant interface. Most current solutions address only a subset of this triad and equate mechanical matching with compliance alone, which can lead to disturbed hemodynamics, maladaptive mechanobiology, and adverse graft-host biochemical interactions that frequently culminate in clinical complications and graft failure. This study presents polyurethane-based heparin-functionalized elastomeric nanofibrillar grafts (H-ENGs) that integrate all three prerequisites while allowing multi-parameter mechanical mimicry. To address the principal failure mode of early thrombosis, a small fraction of polyethyleneimine (PEI) is added to the ENG electrospinning solution to form P-ENGs, enabling one-step covalent heparin conjugation to form H-ENGs. The decoupled design of the ENG platform preserves the biomimetic microstructure and mechanics following PEI incorporation and heparinization, enabling adaptable, indication-specific optimization. In vitro, H-ENGs demonstrate strong benchtop performance, exhibiting a suture retention strength of 2.91 ± 0.40 N and a burst pressure of 634 ± 66 mmHg, both above physiological requirements. Relative to non-heparinized ENG controls, H-ENGs reduce the water contact angle from 117.3° to 90.6°, platelet adhesion density from 410 ± 61 to 35 ± 9 platelets/mm

Indexed as

Biocompatible MaterialsBlood Vessel ProsthesisElastomersHeparinNanofibersAnimalsHumansMaterials TestingParticle SizePolyethyleneiminePolyurethanesThrombosisBiocompatible MaterialsElastomersHeparinPolyethyleneiminePolyurethanesaortic interposition graftelectrospinningheparinizationmechanically biomimeticthromboresistance

Identifiers

PMID42378105
PMCPMC13367417

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.